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b-catenin plays an essential role in several biological events including cell fate determination, cell proliferation, and
transformation. Here we report that b-catenin is encoded by a labile transcript whose half-life is prolonged by Wnt and
phosphatidylinositol 3-kinase–AKT signaling. AKT phosphorylates the mRNA decay-promoting factor KSRP at a unique
serine residue, induces its association with the multifunctional protein 14-3-3, and prevents KSRP interaction with the
exoribonucleolytic complex exosome. This impairs KSRP’s ability to promote rapid mRNA decay. Our results uncover an
unanticipated level of control of b-catenin expression pointing to KSRP as a required factor to ensure rapid
degradation of b-catenin in unstimulated cells. We propose KSRP phosphorylation as a link between phosphatidy-
linositol 3-kinase–AKT signaling and b-catenin accumulation.
Citation: Gherzi R, Trabucchi M, Ponassi M, Ruggiero T, Corte G, et al. (2007) The RNA-binding protein KSRP promotes decay of b-catenin mRNA and is inactivated by PI3K-
AKT signaling. PLoS Biol 5(1): e5. doi:10.1371/journal.pbio.0050005
Introduction
The half-life (t½) of mRNAs is regulated in a complex
fashion in response to external stimuli. Whereas transcripts
containing the AU-rich element (ARE) are labile, activation of
signal transduction pathways induces their stabilization [1]. It
is now clear that mRNA decay regulation by different signals
makes a huge contribution to the global control of gene
expression [1]. AREs, located in the 39 untranslated region (39
UTR) of many short-lived transcripts, promote mRNA dead-
enylation and decapping followed by degradation of the
mRNA body [1,2]. Mammalian ARE-containing transcripts
are thought to be deadenylated by at least one of the seven
known deadenylases and degraded mainly by the exosome, a
multiprotein complex containing 39-59 exonucleases [1,2]. A
relevant role in mRNA decay has been recently demonstrated
for the 59-39 exonuclease Xrn1 [3]. ARE-binding proteins
(ARE-BPs) are trans-acting factors responsible for the decay
control of labile mRNAs [1]. Some ARE-BPs are decay-
promoting factors (TTP, BRF1, KSRP), and others, such as
HuR, are stabilizing factors, whereas AUF1 promotes either
decay or stabilization depending on the cellular context or its
isoform expression proﬁle [1]. According to the recently
proposed recruitment model, destabilizing ARE-BPs interact
with AREs and recruit the degradation machinery to the
mRNA [4–6]. The ARE-BP KSRP, containing four contiguous
K homology (KH) motifs that recognize the AREs and interact
with the mRNA degradation machinery, promotes rapid
decay of several ARE-containing mRNAs both in vitro and in
vivo [4,6].
Activation of the stress-responsive c-Jun N-terminal kinase
[7], p38 MAP kinase [8,9], MAPKAPK2 [10,11], phosphatidy-
linositol 3-kinase (PI3K)-AKT [12,13], and Wnt/b-catenin
signaling [14] was shown to trigger stabilization of various
transcripts, thereby causing large alterations in their abun-
dance. We have previously shown that activation of the Wnt
signaling pathway in pituitary aT3-1 cells induces a coor-
dinate transcriptional and post-transcriptional regulation of
select target genes [14,15]. We proposed that the integrated
regulation of transcription and mRNA turnover is required
to ensure rapid and relevant changes in the expression of
regulatory genes [9,14].
Recently, we observed that a common set of transcripts is
stabilized by either treatment with lithium chloride (LiCl), a
mimicker of Wnt signaling [16], or AKT activation in
pituitary aT3-1 cells (unpublished data). Among these tran-
scripts, we found b-catenin. b-catenin plays a key role in
embryonic development and tumorigenesis by controlling
the expression of Wnt-responsive genes [17–19]. In response
to Wnt signals, Dishevelled is recruited to the Axin complex
to inhibit glycogen synthase kinase-3b, resulting in cytosolic
accumulation and subsequent translocation of b-catenin to
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PLoS BIOLOGYthe nucleus, where it binds to transcription factors of the T-
cell factor/lymphoid enhancer factor family and transacti-
vates Wnt target genes [17,18]. Serine/threonine kinases
belonging to the AKT family are major effectors of the
PI3K pathway and are activated by insulin and other
polypeptide growth factors [20,21]. The recruitment of AKT
to the plasma membrane by the lipid products of PI3K leads
to AKT phosphorylation and activation [20,21]. Once
activated, AKT exerts a central role in metabolism, cell
survival, motility, transcription, and cell-cycle progression
[21–23]. Cross-talks between Wnt and PI3K-AKT signaling
pathways have been described [24–27].
In this report, we describe that b-catenin mRNA is labile
due to destabilizing elements located in its 39 UTR and that
KSRP is a major molecular determinant of b-catenin mRNA
instability. b-catenin transcript can be stabilized by either
Wnt or PI3K-AKT signaling activation. AKT phosphorylates
KSRP at a unique serine residue favoring its interaction with
the adaptor protein 14-3-3. As a consequence, KSRP fails to
interact with the exosome and, in turn, b-catenin mRNA is
stabilized.
Results
b-Catenin Is Encoded by a Labile mRNA Whose Half-Life Is
Prolonged by Wnt Signaling
We previously reported that the treatment of mouse
pituitary aT3-1 cells with LiCl (a compound widely used to
mimic Wnt signaling [16]) stabilizes select ARE-containing
labile transcripts [14]. To identify additional ARE-containing
transcripts whose mRNA t½ is prolonged in aT3-1 cells in
response to LiCl treatment, a large-scale analysis using the
ARE-cDNA microarray system was performed [28]. The
microarray screening revealed that LiCl treatment signiﬁ-
cantly upregulated, among others, b-catenin mRNA (unpub-
lished data). By both semiquantitative and quantitative RT-
PCR, we conﬁrmed that b-catenin mRNA increased by
approximately fourfold in cells treated with LiCl (Figure 1A
and unpublished data). The inspection of mouse b-catenin 39
UTR revealed the presence of several U-rich regions spread
over the entire sequence (classiﬁed as class III AREs [28 and
references cited therein]). As shown in Figure 1B, quantita-
tive PCR experiments demonstrated that b-catenin mRNA
was unstable in intact aT3-1 cells displaying a t½ of
approximately 45 min, whereas the control b2-microglobulin
(b2-MG) was stable. In order to verify whether b-catenin
AREs were responsible for the rapid decay of the endogenous
transcript, we transfected aT3-1 cells with a reporter plasmid
containing the entire b-catenin 39 UTR placed at the 39 end
of chloramphenicol acetyltransferase (CAT) sequence. As
shown in Figure 1C, CAT-b-catenin chimeric transcript
displayed a short t½ while control CAT mRNA was stable.
Next, we investigated whether Wnt signaling activation
regulates b-catenin mRNA turnover in intact cells. As shown
in Figure 1D, LiCl treatment signiﬁcantly prolonged the t½ of
b-catenin mRNA while the t½ of b2-MG was unaffected.
Furthermore, treatment of aT3-1 cells with recombinant
mouse Wnt-3A increased b-catenin mRNA steady-state levels
(Figure 1E). Importantly, Wnt-3A treatment strongly pro-
longed b-catenin t½ in intact cells (Figure 1F).
These results suggest that b-catenin mRNA is labile in
unstimulated cells due to the presence of AREs in its 39 UTR.
Wnt signaling activation stabilizes b-catenin mRNA and
induces its accumulation.
PI3K-AKT Activation Stabilizes b-Catenin mRNA and
Increases Both mRNA and Protein Steady-State Levels
As previously reported, besides mimicking the activation of
the canonical Wnt pathway, LiCl also targets PI3K-AKT
signaling [29,30]. Furthermore, the results of our ARE-cDNA
microarray screening revealed that LiCl treatment and AKT
activation, obtained expressing a constitutively active myr-
istylated form of AKT1 (myrAKT1 [31]), induced stabilization
of a common set of mRNAs including b-catenin (unpublished
data). These observations prompted us to investigate the
effect of PI3K-AKT activation on b-catenin mRNA turnover.
First, we assessed the contribution given by PI3K-AKT
pathway to LiCl-induced b-catenin mRNA stabilization. We
used both pharmacological inhibitors and an AKT dominant
negative mutant [AKT1(K179M)] to block PI3K-AKT signal-
ing. We found that treatment with either LY294002 (LY, a
PI3K inhibitor [32]) or triciribine (a speciﬁc AKT inhibitor
[33]) strongly reduced LiCl-induced stabilization of b-catenin
mRNA in intact aT3-1 cells (Figure 2A and 2B). Similarly,
AKT1(K179M) expression impaired LiCl-induced stabiliza-
tion of b-catenin mRNA in vitro (Figure 2C).
Next, we expressed myrAKT1 in aT3-1 cells. As shown in
Figure 2D, the kinase activity immunoprecipitated with anti-
AKT antibody was ﬁvefold higher in aT3-1–myrAKT1 than in
mock aT3-1 cells, thus demonstrating that active AKT kinase
was present in extracts from cells expressing myrAKT1. The
steady-state levels of b-catenin mRNA were increased and b-
catenin mRNA t½ was prolonged in aT3-1–myrAKT1 cells
(Figure 2E and 2F). myrAKT1 expression produced a similar
stabilization of b-catenin mRNA in murine C2C12 myoblasts
(C2C12-myrAKT1, Figure S1). Importantly, we observed a
strong increase of b-catenin protein levels in both nuclear
and cytosolic compartments of aT3-1–myrAKT1 and C2C12-
myrAKT1 cells compared with control cells (Figure 2G and
unpublished data).
These results suggest that PI3K-AKT activation stabilizes b-
catenin mRNA, leading to mRNA and protein accumulation.
Author Summary
During mammalian development and adulthood, b-catenin regu-
lates the transcription of a family of genes with multiple essential
roles in cell proliferation and differentiation. b-catenin also plays a
role in cancer when it carries mutations that result in uncontrolled b-
catenin function. Here, we report that the lifetime of the b-catenin–
encoding transcript is under regulatory control. We show that
specific cellular signals relevant to proper mammalian development
and implicated in tumor formation can prolong b-catenin transcript
half-life, leading to the accumulation of b-catenin protein. We
identify a molecular mechanism for this prolongation by showing
that a protein factor responsible for b-catenin transcript instability
(and thus degradation) is impaired by phosphorylation, a chemical
modification. When this factor is impaired, b-catenin mRNA and
protein accumulate. Our results point to an unanticipated control of
b-catenin levels through regulation of its transcript half-life in
response to signals related to proliferation and differentiation.
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KSRP Required for b-Catenin mRNA DecayInsulin-Induced PI3K-AKT Activation Stabilizes b-Catenin
mRNA and Increases Both mRNA and Protein Steady-State
Levels
In order to verify whether insulin-induced AKT activation
affects b-catenin mRNA stabilization, we used insulin
receptor–overexpressing HIRc-B rat cells, which display
strong responses to insulin [13,34]. Indeed, the kinase activity
immunoprecipitated with anti-AKT antibody was approxi-
mately sixfold higher in insulin-treated than in control HIRc-
B cells, and LY treatment strongly reduced insulin-dependent
AKT activation (Figure 3A). Figure 3B shows that insulin
increased b-catenin mRNA steady-state levels and that LY
treatment almost completely blocked insulin effect. b-catenin
mRNA was signiﬁcantly stabilized by insulin in intact HIRc-B
cells, and LY treatment strongly decreased insulin-induced b-
catenin mRNA stabilization (Figure 3C). Accordingly, insulin
induced b-catenin protein accumulation in both cytosolic
and nuclear fractions from HIRc-B cells (Figure 3D). To
investigate whether insulin affects b-catenin protein degra-
dation rate, we treated HIRc-B cells with cycloheximide, to
inhibit translational elongation, and monitored b-catenin
levels in total extracts after different intervals of time. As
shown in Figure 3E, insulin did not affect the rate of b-
catenin protein decay.
In conclusion, a physiological activation of PI3K-AKT
signaling causes stabilization of b-catenin transcript and
Figure 1. mRNA Encoding b-Catenin Is Labile and Is Stabilized by LiCl and Wnt-3A
(A) Expression of b-catenin and b2-MG (control transcript), monitored by RT-PCR, in control and in LiCl-treated (20 mM for 6 h) aT3-1 cells.
(B) Quantitative RT-PCR analysis of both b-catenin and b2-MG transcripts in aT3-1 cells. Total RNA was isolated at the indicated times after addition of
actinomycin D. The values shown are averages (6SEM) of three independent experiments performed in duplicate.
(C) Quantitative RT-PCR analysis of both CAT and CAT–b-catenin transcripts in either CAT or CAT–b-catenin transiently transfected aT3-1 cells. Total RNA
was isolated at the indicated times after addition of actinomycin D. The values shown are averages (6SEM) of three independent experiments
performed in duplicate.
(D) Semiquantitative RT-PCR analysis of both b-catenin and b2-MG transcripts in either control or LiCl-treated aT3-1 cells. Total RNA was isolated at the
indicated times after the addition of actinomycin D. The amount of each transcript was quantitated by densitometry and plotted using a linear
regression program. The values shown are averages (6SEM) of three independent experiments performed in duplicate.
(E) Expression of b-catenin and b2-MG, monitored by RT-PCR, in either control-treated aT3-1, or Wnt-3A–treated (10 ng/ml, 6 h) aT3-1 cells.
(F) Semiquantitative RT-PCR analysis of both b-catenin and b2-MG transcripts in either control or Wnt-3A–treated aT3-1 cells. Total RNA was isolated at
the indicated times after the addition of actinomycin D. The amount of each transcript was quantitated and represented as described in (D).
doi:10.1371/journal.pbio.0050005.g001
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KSRP Required for b-Catenin mRNA Decayincreases steady-state levels of both b-catenin mRNA and
protein.
The mRNA Destabilizing Factor KSRP Is Phosphorylated by
AKT
We hypothesized that AKT activation stabilizes b-catenin
transcript by targeting the mRNA decay machinery. Among
ARE-BPs known to affect mRNA turnover, only KSRP [4] and
HuR [35] were able to speciﬁcally immunoprecipitate b-
catenin mRNA in RNA-immunoprecipitation experiments
(Figure 4A). We ﬁrst investigated whether AKT was able to
phosphorylate either KSRP or HuR. KSRP was phosphory-
lated by recombinant puriﬁed AKT2 in vitro, whereas HuR
was not phosphorylated (Figure 4B). In silico analysis (Motif
Scan, http://scansite.mit.edu/motifscan_seq.phtml) of the
h u m a nK S R Pp r i m a r ys e q u e n c ep e r f o r m e da tm e d i u m
stringency indicated serine 193 (bold in the following
peptide: GLPERSVSLTGAPES) as a potential AKT phosphor-
Figure 2. PI3K-AKT Signaling Stabilizes b-Catenin mRNA and Increases Its Expression
(A) Quantitative RT-PCR analysis of both b-catenin and b2-MG transcripts in aT3-1 cells treated with either DMSO (the solvent of LY, control), DMSO plus
LiCl, or LY (25 lM for 16 h) plus LiCl. Total RNA was isolated at the indicated times after the addition of actinomycin D. The values shown are averages
(6SEM) of three independent experiments performed in duplicate.
(B) Quantitative RT-PCR analysis of both b-catenin and b2-MG transcripts in aT3-1 cells treated with either DMSO (the solvent of triciribine, control),
DMSO plus LiCl (20 mM for 6 h), or triciribine (1 lM for 1 h) plus LiCl. Total RNA was isolated at the indicated times after the addition of actinomycin D.
The values shown are averages (6SEM) of three independent experiments performed in duplicate.
(C) In vitro RNA degradation assays using S100s from either LiCl-treated mock aT3-1 or LiCl-treated aT3-1 cells expressing the AKT dominant negative
mutant AKT1(K179M) (aT3-1–AKTDN). Internally
32P-labeled and capped RNA substrates were incubated with S100s for the indicated times and their
decay analyzed as described in Materials and Methods.
(D) Either mock aT3-1 or aT3-1–myrAKT1 cells were lysed and total extracts were immunoprecipitated (Ip) with either anti-AKT antibody or control IgG
(cIgG). Pellets were incubated (20 min at 30 8C) with histone 2B (H2B) in kinase buffer in the presence of [c-
32P]ATP. Labeled proteins were separated by
SDS-PAGE and detected by autoradiography.
(E) Expression of b-catenin and b2-MG, monitored by RT-PCR, in either mock aT3-1 or aT3-1–myrAKT1 cells.
(F) Quantitative RT-PCR analysis of both b-catenin and b2-MG transcripts in either mock aT3-1 or aT3-1–myrAKT1 cells. Total RNA was isolated at the
indicated times after addition of actinomycin D. The values shown are averages (6SEM) of three independent experiments performed in duplicate.
(G) Immunoblot analysis of either S100 or nuclear extracts from the indicated cell lines with anti- b-catenin, a-tubulin, and HDAC2 antibodies.
doi:10.1371/journal.pbio.0050005.g002
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KSRP Required for b-Catenin mRNA Decayylation site (asterisk in Figure 4C, left). We evaluated the
ability of AKT2 to phosphorylate KSRP deletion mutants
expressed as GST-fusion proteins (Figure 4C). Only the KSRP
fragments including KH1, where S193 is located, were
phosphorylated by AKT2 in a concentration-dependent
manner (Figure 4C, lanes 1, 3, 4, and 6, and unpublished
data). Importantly, myrAKT1 expression enhanced the
phosphorylation of coexpressed FLAG-KSRP while not
affecting FLAG-KSRP(S193A) mutant, as shown by anti-FLAG
immunoprecipitation following [
32P]orthophosphate meta-
bolic labeling of intact HeLa cells (Figure 4D). In order to
unambiguously identify the KSRP residue(s) phosphorylated
by AKT, recombinant human KSRP was phosphorylated by
AKT2 in vitro, the gel band was digested with trypsin and
Figure 3. Insulin Stabilizes b-Catenin mRNA and Increases Its Expression
(A) HIRc-B cells were treated for 1 h with DMSO (control), insulin (10
 6 M) plus DMSO, or LY (25 lM for 16 h) plus insulin. Total extracts were
immunoprecipitated with either anti-AKT antibody or control IgG (cIgG). Pellets were incubated (20 min at 30 8C) with histone 2B (H2B) in kinase buffer
in the presence of [c-
32P]ATP. Labeled proteins were separated by SDS-PAGE and detected by autoradiography.
(B) Expression of b-catenin and b2-MG, monitored by RT-PCR, in control HIRc-B cells and in HIRc-B treated with either insulin or LY plus insulin.
(C) Quantitative RT-PCR analysis of both b-catenin and b2-MG transcripts in control HIRc-B cells, in HIRc-B treated with either insulin or LY plus insulin.
Total RNA was isolated at the indicated times after the addition of actinomycin D. The values shown are averages (6SEM) of three independent
experiments performed in duplicate.
(D) Immunoblot analysis of either S100 or nuclear extracts from either control- or insulin-treated HIRc-B cells with anti–b-catenin, b-actin, and HDAC2
antibodies. The amount of each band was quantitated by densitometry and insulin was found to increase b-catenin expression by 3.2- and 2.1-fold over
the control in S100 and nuclear extracts, respectively.
(E) HIRc-B cells were maintained for 16 h in DMEM containing 0.1% FCS; then either PBS (control) or insulin (10
 6 M) was added for 1 h. Cultures were
then treated with cycloheximide (50 lg/ml) for the indicated times. Total cell extracts were prepared, and the levels of b-catenin quantitated by
immunoblotting and densitometric scanning. Results are the average (6SEM) of three experiments. b-Actin immunoblotting was used to verify the
equal protein loading.
doi:10.1371/journal.pbio.0050005.g003
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KSRP Required for b-Catenin mRNA Decayenriched for phosphopeptides, and the peptides were
analyzed by nanoﬂow liquid chromatography–tandem mass
spectrometry (LC-MS/MS). This led to the identiﬁcation of
the unique peptide SV[pS]LTGAPESVQK with phosphoryla-
tion at the second serine residue (S193) (Figure 4E). The
entire sequence of the phosphorylated peptide is perfectly
conserved in several mammalian species (Mus musculus, Rattus
norvegicus, Canis familiaris, and Bos taurus), and the phosphory-
lated serine is conserved, in a corresponding position, also in
nonmammalian species (Gallus gallus, Xenopus laevis, and Danio
rerio) (unpublished data). S193 was mutated to alanine in
KH1-4 and KH1-2, and the mutant proteins were expressed
in bacteria. As shown in Figure 4F, the S193A mutation
abolished AKT-dependent phosphorylation in vitro.
Figure 4. KSRP Is Phosphorylated by AKT in Serine 193
(A) Immunoprecipitation of b-catenin RNA-containing ribonucleoprotein complexes. The proteins were immunoprecipitated from aT3-1 total cell
extracts using the indicated antibodies. RNA was extracted from the immune complexes and analyzed by RT-PCR as indicated.
(B) Either highly purified recombinant human KSRP (lanes 1 and 2) or affinity-purified GST-HuR (lanes 3 and 4) was incubated with either active
recombinant AKT2 in kinase buffer or buffer alone in the presence of [c-
32P]ATP. Labeled proteins were separated by SDS-PAGE, blotted to nylon
membranes, and detected by autoradiography (top panel). Immunoblot analysis of the above kinase reactions with either anti-KSRP (middle panel) or
anti-GST (bottom panel) antibodies.
(C) Schematic representation of KSRP and GST-fused deletion mutants. Asterisks indicate the position of a putative AKT phosphorylation site (left). AKT2
kinase assays were performed using the indicated recombinant protein substrates (middle and right). Arrows point to the position of each
phosphorylated protein; the asterisk marks the position of phosphorylated AKT2.
(D) In vivo [
32P]orthophosphate metabolic labeling of HeLa cells transiently cotransfected with either FLAG-KSRP plus empty pcDNA3, or FLAG-KSRP
plus pCMV–myr-AKT1, or FLAG-KSRP(S193A) plus pCMV–myr-AKT1. Aliquots of the lysates were immunoprecipitated with protein A–protein G–
Sepharose–bound mouse control IgG (cIgG) or anti-FLAG antibody, separated by SDS-PAGE, and autoradiographed (top panel). Immunoblot analysis of
the above in vivo phosphorylation reactions with anti-FLAG antibody (bottom panel). Arrows point to the position of transfected KSRP.
(E) MS-MS fragmentation spectrum of the tryptic peptide SV[pS]LTGAPESVQK of KSRP showing phosphorylation of S193.
(F) AKT2 kinase assays using the indicated recombinant protein substrates. Arrows point to the position of each phosphorylated protein; the asterisk
marks the position of phosphorylated AKT2.
doi:10.1371/journal.pbio.0050005.g004
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human KSRP at the unique site S193.
KSRP Controls b-Catenin mRNA Turnover in aT3-1 Cells
The results presented above indicated that KSRP was
phosphorylated by AKT and led us to hypothesize that KSRP
could be involved in AKT-induced stabilization of b-catenin
mRNA. We and others demonstrated that KSRP regulates the
stability of select mRNAs in response to different stimuli
[9,36]. Thus, we investigated whether KSRP controls the decay
rate of b-catenin mRNA. Stable knock-down of KSRP
obtained using shRNA in aT3-1 cells (aT3-1–shKSRP, Figure
5A) led to a more than fourfold increase of the steady-state
levels of b-catenin mRNA when compared to mock-trans-
fected cells (Figure 5B). Furthermore, b-catenin mRNA was
stable in aT3-1–shKSRP in vivo (Figure 5C) and in vitro
(Figure S2A). Conversely, KSRP overexpression in aT3-1 cells
blocked the LiCl-induced stabilization of b-catenin mRNA
(Figure S2B). Importantly, b-catenin protein levels were
approximately fourfold higher in aT3-1–shKSRP than in
control cells, although b-catenin protein decay rates were
unchanged (Figure 5D and 5E). The increase in b-catenin
expression was mirrored by an increase in luciferase activity
driven by two b-catenin–responsive reporters, TOP-FLASH
and mouse c-myc promoter region (Figure 5F).
We ruled out the possibility that AKT activation could
change KSRP expression levels affecting its protein stability.
As shown in Figure S3, expression of myrAKT1 in aT3-1 cells
did not affect either KSRP steady-state levels (Figure S3A) or
protein stability (Figure S3B)
Altogether, these results indicate that KSRP is crucial in
controlling b-catenin mRNA decay and, in turn, b-catenin
expression.
14-3-3 Interacts with Phosphorylated KSRP and Affects Its
Decay-Promoting Activity
To investigate the functional consequences of KSRP
phosphorylation by AKT, we performed in vitro reconstitu-
tion experiments. Either nonphosphorylated or AKT2-phos-
phorylated KSRP was added to S100 extracts from aT3-1–
shKSRP in typical in vitro degradation assays. As presented in
Figure 6, KSRP promoted rapid decay of b-catenin mRNA,
whereas AKT2-phosphorylated KSRP lacked its decay-pro-
moting ability (Figure 6A). Similar results were obtained
using KH1-4 as a GST fusion instead of the Baculovirus-
expressed KSRP (Figure 6E). As predictable on the basis of the
results shown in Figure 4F, the incubation of the mutant
KH1-4(S193A) with AKT2 did not affect its b-catenin RNA
decay-promoting activity (Figure 6A, lanes 17–28).
The sequence of the peptide including S193 closely
resembles the phosphoserine-containing motif that is recog-
nized by members of the 14-3-3 protein family [37]. Indeed,
in a yeast two-hybrid screening performed in order to
identify molecular partners of KSRP, we found, among
others, the cDNA encoding 14-3-3f (unpublished data). To
investigate whether phosphorylation by AKT favors the
interaction of KSRP with 14-3-3, we cotransfected either
myrAKT1 or the empty vector (mock) together with FLAG-
KSRP [9] in 293T cells. The kinase activity immunoprecipi-
tated by anti-AKT antibody was higher in myrAKT-293T
than in mock 293T cells (unpublished data). Endogenous 14-
3-3 coimmunoprecipitated with FLAG-KSRP only in cells
transfected with myrAKT1 (Figure 6B). Accordingly, GST–
KH1-4 pulled down endogenous 14-3-3 present in extracts
from aT3-1 cells stably expressing myrAKT1 but not from
mock aT3-1 cells (Figure 6C). As predictable on the basis of
the position of the unique AKT phosphorylation site (S193),
only GST-KSRP fusion proteins containing the KH1 inter-
acted with 14-3-3 (Figure 6C, lanes 6, 9, and 10). We
examined whether phosphorylated S193 is required for
KSRP interaction with 14-3-3. Coimmunoprecipitation ex-
periments showed that wild-type KSRP interacted with 14-3-
3 when coexpressed with myrAKT1 in 293T cells, whereas
KSRP(S193A) did not (Figure 6D). Accordingly, the S193A
mutant KH1-4 [GST–KH1-4(S193A)] failed to interact with
14-3-3 in pull-down experiments (unpublished data). To
inhibit the interaction between AKT-phosphorylated KSRP
and 14-3-3, we used the synthetic peptide difopein, which
binds to 14-3-3 proteins with high afﬁnity and competitively
inhibits 14-3-3–ligand interaction [38]. AKT2-phosphory-
lated KSRP was preincubated with either a scrambled
peptide (control) or difopein, as indicated, before incubation
with S100 extracts from aT3-1–shKSRP cells and used in in
vitro RNA degradation experiments. Data presented in
Figure 6E indicate that preincubation with difopein restored
the decay-promoting activity of KH1-4, preventing the
interaction of phosphorylated KH1-4 protein with 14-3-3
(Figure 6F).
Altogether, our results indicate that AKT-phosphorylated
KSRP interacts with 14-3-3 and that this interaction impairs
the decay-promoting activity of KSRP in vitro.
AKT Activation Impairs the Interaction of KSRP with the
Exosome
We investigated whether the impairment of the mRNA
decay-promoting activity of KSRP upon phosphorylation by
AKT2 (see Figure 6A) was due to either reduced RNA binding
or reduced interaction with the decay machinery. In vitro
phosphorylation by AKT2 did not affect the b-catenin mRNA
binding activity of KSRP either in the absence or in the
presence of recombinant 14-3-3f (Figure 7A and 7B).
Coimmunoprecipitation experiments performed in 293T
cells showed that expression of myrAKT1 impaired the
interaction of KSRP with core exosome components includ-
ing hRrp4p and hRrp41 and with the exosome-associated
factor hMtr4p [39] (Figure 7C and unpublished data), whereas
it did not affect the interaction with the deadenylase PARN.
Similarly, in GST pull-down experiments, GST–KH1-4 inter-
acted with hRrp4p and hMtr4p present in aT3-1 total
extracts, whereas GST–KH1-4 phosphorylated in vitro by
AKT2 failed to interact (Figure 7D). Difopein, competing the
interaction between GST–KH1-4 and 14-3-3 (see Figure 6F),
restored the ability of GST–KH1-4 to pull-down hRrp4p and
hMtr4p (Figure 7E).
The evidence that myrAKT1 expression does not affect the
interaction of KSRP with PARN prompted us to investigate
whether b-catenin mRNA deadenylation was affected by
myrAKT1 expression in aT3-1 cells. As shown in in vitro
degradation experiments presented in Figure 7F, deadeny-
lated b-catenin mRNA accumulated in aT3-1–myrAKT1 cells.
Our results suggest that phosphorylation by AKT and
interaction with 14-3-3 affect the ability of KSRP to interact
with the exosome.
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KSRP Required for b-Catenin mRNA DecayDiscussion
Here we report that b-catenin is encoded by a labile
transcript whose t½ is prolonged by Wnt and PI3K-AKT
signaling. The mRNA decay-promoting factor KSRP is
required to ensure rapid degradation of b-catenin transcript
in unstimulated cells. AKT phosphorylates KSRP at a unique
serine residue, creating a functional binding site for the
molecular chaperone 14-3-3. As a consequence, AKT activa-
tion impairs KSRP ability to interact with the exoribonu-
cleolytic complex exosome and, in turn, to promote rapid
mRNA decay.
b-Catenin mRNA Is Labile and Its Degradation Rate Is
Controlled by the ARE-BP KSRP
With its involvement in the Wnt signal transduction
pathway and tumorigenesis, b-catenin is an extensively
studied protein. However, the vast majority of studies
focused on the control of b-catenin protein degradation
upon its signal-induced phosphorylation [17–19]. Lopez de
Silanes et al. [40] identiﬁed b-catenin mRNA as a target of the
ARE-BP HuR in colon cancer cells, leading to the hypothesis
that b-catenin is encoded by a labile mRNA. Our results
demonstrate that b-catenin mRNA is labile in unstimulated
cells and point to an unanticipated mechanism by which b-
catenin expression can be regulated at the level of its mRNA
turnover by PI3K-AKT activation. Knock-down experiments
demonstrate that KSRP controls the t½ and the steady-state
levels of b-catenin mRNA, thus increasing b-catenin protein
levels and enhancing the b-catenin–dependent TOP-FLASH–
and c-myc promoter–dependent reporter transcription.
Notably, KSRP knock-down did not affect b-catenin protein
degradation rate. While this manuscript was in preparation, a
Figure 5. KSRP Is Required for b-Catenin mRNA Degradation
(A) Immunoblot analysis of total extracts from either mock aT3-1 (empty pSUPER-Puro vector-transfected) or aT3-1-shKSRP (pSUPER-Puro-shKSRP–
transfected) cells using affinity-purified anti-KSRP and anti–a-tubulin antibodies.
(B) Expression of b-catenin and b2-MG, monitored by RT-PCR, in either mock aT3-1 or aT3-1–shKSRP cells.
(C) Quantitative RT-PCR analysis of both b-catenin and b2-MG transcripts in either mock aT3-1 or aT3-1–shKSRP cells. Total RNA was isolated at the
indicated times after the addition of actinomycin D. The values shown are averages (6SEM) of three independent experiments performed in duplicate.
(D) Immunoblot analysis of total extracts from the indicated cell lines with anti–b-catenin and a-tubulin antibodies.
(E) Either mock aT3-1 or aT3-1–shKSRP cells were treated with cycloheximide (50 lg/ml) for the indicated times. Total cell extracts were prepared and
the levels of b-catenin quantitated by immunoblotting and densitometric scanning. Results are the average (6SEM) of three experiments. a-Tubulin
immunoblotting was used to verify the equal protein loading.
(F) Either mock aT3-1 or aT3-1–shKSRP cells were transiently transfected with either TOP-FLASH or c-myc-LUC reporter vectors, cultured for 2 d, and
collected, and luciferase activity was measured. The values shown are averages (6SEM) of four independent experiments performed in duplicate.
doi:10.1371/journal.pbio.0050005.g005
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alternative splicing in the 39 UTR of human b-catenin mRNA
that could inﬂuence its stability. However, we exclude that
alternatively spliced isoforms exist in the 39 UTR of mouse b-
catenin mRNA in aT3-1 and C2C12 cells (Figure S4 and
unpublished data). Surprisingly, Thiele et al. [41] reported
that AREs in the 39 UTR of human b-catenin mRNA are
stabilizing elements. Our results indicate that b-catenin
transcript is unstable in four different cell lines (aT3-1,
HIRc-B, C2C12 as presented in this report, and 293T,
unpublished data) and that mouse b-catenin 39 UTR confers
instability to a reporter mRNA. These data are in agreement
with the general view that AREs are destabilizing elements in
unstimulated cells (reviewed in [1–3]).
Figure 6. KSRP Phosphorylation by AKT Promotes Its Interaction with 14-3-3 and Affects Its mRNA-Destabilizing Function
(A) In vitro RNA degradation assays using S100s from either mock aT3-1 (lanes 1–4) or aT3-1–shKSRP cells (lanes 5–28) preincubated with BSA (lanes 1–
8), GST (lanes 17–20), KSRP (30 nM, lanes 9–12), AKT2-phosphorylated KSRP (30 nM, lanes 13–16), KH1-4 (S193A) (30 nM, lanes 21–24), or AKT2-
phosphorylated KH1-4(S193A) (30 nM, lanes 25–28), respectively. Internally
32P-labeled and capped RNA substrates were added, and their decay was
monitored as described above.
(B) Coimmunoprecipitation of FLAG-KSRP and endogenous 14-3-3 in 293T cells transiently transfected with FLAG-KSRP and either pCMV empty vector
(mock 293T) or pCMV-myrAKT1 (293T-myrAKT1). Cell lysates were immunoprecipitated as indicated and analyzed by immunoblotting using anti–14-3-3
antibody.
(C) GST pull-down of endogenous 14-3-3 from total extracts of either mock aT3-1 (lanes 1–3) or aT3-1–myrAKT1 (lanes 4–11) cells using either control
GST, GST–KH1-4, or the additional KSRP deletion mutants fused with GST (as indicated, see Figure 4B for a schematic representation of KSRP deletion
mutants). Proteins were analyzed by immunoblotting using anti–14-3-3 antibody.
(D) Coimmunoprecipitation of either FLAG-KSRP or FLAG-KSRP(S193A) and endogenous 14-3-3 in 293T cells transiently transfected with pCMV-myrAKT1
(293T-myrAKT1) and either FLAG-KSRP or FLAG-KSRP(S193A). Cell lysates were immunoprecipitated as indicated and analyzed by immunoblotting using
anti–14-3-3 antibody.
(E) In vitro RNA degradation assays using S100s from aT3-1–shKSRP cells pre-incubated with either GST (lanes 1–4), KH1-4 (30 nM, lanes 5–8), AKT2-
phosphorylated KH1-4 (30 nM, lanes 9–12), or AKT2-phosphorylated KH1-4 (30 nM) preincubated with difopein (50 nM) (lanes 13–16), respectively.
Internally
32P-labeled and capped RNA substrates were added, and their decay monitored was as described above.
(F) GST pull-down of endogenous 14-3-3 from total extracts of aT3-1-myrAKT1 cells using either control GST, GST–KH1-4, or GST–KH1-4 preincubated
with 50 nM difopein (as indicated). Proteins were analyzed by immunoblotting using anti–14-3-3 antibody.
doi:10.1371/journal.pbio.0050005.g006
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by Targeting KSRP
Our data suggest that PI3K-AKT signaling stabilizes b-
catenin transcript targeting the mRNA decay machinery. In
the past, conﬂicting results on PI3K-AKT–induced control of
b-catenin protein degradation have been provided [42–45].
The discrepancies might depend on the divergent regulation
of protein decay in different cell types. Indeed, we have
observed that insulin-induced PI3K-AKT activation does not
affect b-catenin protein stability in HIRc-B cells (Figure 3E),
Figure 7. AKT Activation Affects KSRP-Exosome Interaction
(A) The interaction between
32P-labeled ARE b-catenin RNA and recombinant purified KSRP (increasing amounts from 30 to 300 nM) subjected to kinase
reactions in the absence or in the presence of AKT2 (as indicated) was evaluated by UV-crosslinking.
(B) The interaction between
32P-labeled ARE b-catenin RNA and recombinant purified KSRP (50 nM) subjected to AKT2 phosphorylation in the presence
of either GST (50 nM) or GST–14-3-3 (50 nM, as indicated) was evaluated by UV-crosslinking.
(C) Coimmunoprecipitation of FLAG-KSRP and either endogenous exosome components (hRrp4p and hMtr4p, as indicated) or endogenous
deadenylase PARN in 293T cells transiently transfected with FLAG-KSRP and either pCMV empty vector (mock-293T) or pCMV-myrAKT1 (293T-myrAKT1).
Cell lysates were immunoprecipitated as indicated and analyzed by immunoblotting using the indicated antibodies.
(D) GST pull-down of endogenous hRrp4p and hMtr4p from total extracts of aT3-1 cells using GST–KH1-4 subjected to kinase reaction either in the
absence or in the presence of AKT2. Proteins were analyzed by immunoblotting using the indicated antibodies. Asterisks indicate antibody cross-
reactivity with GST-fusion proteins.
(E) GST pull-down of endogenous hRrp4p and hMtr4p from total extracts of aT3-1–myrAKT1 cells using either control GST, GST–KH1-4, or GST–KH1-4
preincubated with 50 nM difopein (as indicated). Proteins were analyzed by immunoblotting using either anti-hRrp4p or anti-hMtr4p antibodies.
(F) In vitro RNA degradation assays using S100s from either mock aT3-1 or aT3-1–myrAKT1 cells. Internally
32P-labeled, capped, and polyadenylated b-
catenin and GAPDH RNA substrates were incubated with S100s for the indicated times, and their decay was analyzed as described in Materials and
Methods. Arrows point to either poly(A)
þ or poly(A)
  b-catenin RNA species.
doi:10.1371/journal.pbio.0050005.g007
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protein t½ in aT3-1 cells (unpublished data). However, our
results indicate that PI3K-AKT consistently induces b-catenin
mRNA stabilization and protein accumulation in both cell
lines. Even though our data indicate that PI3K-AKT
activation, regulating the mRNA decay machinery, can lead
to b-catenin protein accumulation in the absence of changes
in its protein degradation rate, it is conceivable that an
integrated control of both mRNA and protein stability could
be required to ensure rapid and sustained changes of b-
catenin expression in response to certain proliferative and
differentiative cues. Notably, AKT-induced interaction of b-
catenin protein with 14-3-3 has been shown to increase both
b-catenin levels and its transcriptional activity [26]. There-
fore, AKT-dependent interaction of 14-3-3 either with a
factor involved in b-catenin mRNA turnover, such as KSRP,
or with b-catenin itself can lead to accumulation of b-catenin
protein. In a sense, 14-3-3 might be considered a biological
switch controlling b-catenin expression at different levels.
KSRP, a major regulator of b-catenin mRNA decay, is
phosphorylated by AKT at a unique residue (S193). It is a
general concept that destabilizing ARE-BPs, including BRF1,
KSRP, and TTP, are responsible for rapid decay of labile
mRNAs in unstimulated cells recruiting the mRNA decay
machinery [4–6]. We and others have previously shown that
activation of the PI3K-AKT pathway controls the turnover of
select mRNAs targeting either BRF1 or TTP and turning off
their mRNA destabilizing function [12,13,46]. It is noteworthy
that, in our experimental model, KSRP and HuR are the
major ARE-BPs interacting with b-catenin mRNA. PI3K-AKT
activation does not affect the expression level and the
phosphorylation status of HuR while inducing KSRP phos-
phorylation. It is possible to hypothesize that a certain
signaling pathway can affect the turnover of select mRNAs
regulating the function of distinct ARE-BPs, depending on
the cellular context. On the other hand, the activation of
different pathways can affect the turnover of different sets of
transcripts targeting the same ARE-BP. In C2C12 myoblasts,
MAPK p38 activation prolongs the t½ of select myogenic
transcripts inhibiting KSRP function [9], whereas PI3K-AKT
activation does not affect the stability of the same mRNAs
(unpublished data). Similarly, p38 activation in aT3-1 cells
does not affect the t½ of b-catenin mRNA (unpublished data).
How the decay of distinct sets of transcripts can be
speciﬁcally regulated by different signaling pathways that
target the same ARE-BP is still an unsolved issue.
KSRP Interacts with 14-3-3 in a Serine 193–Dependent
Way
Our data indicate that KSRP phosphorylation by PI3K-
AKT creates a functional 14-3-3 binding site. Our current and
previous ﬁndings, together with existing literature [13,47,48],
suggest that 14-3-3 family members play a regulatory role on
the function of some destabilizing ARE-BPs.
Phosphorylation by AKT, followed by interaction with 14-
3-3, impairs the ability of KSRP to promote b-catenin mRNA
decay, reducing KSRP interaction with the 39-59 exoribonu-
cleolytic complex exosome while leaving unaffected the
ability of KSRP to interact with the mRNA. The results
obtained using the high-afﬁnity 14-3-3 competitor peptide
difopein suggest that KSRP–14-3-3 interaction is implicated
in this process. Unexpectedly, we found that AKT activation
does not affect KSRP interaction with the deadenylase PARN
and that deadenylated b-catenin mRNA accumulates when
incubated with S100 from aT3-1-myrAKT1 cells in in vitro
degradation assays. We previously demonstrated that KSRP
associates with mRNA decay enzymes, including PARN and
the exosome components [4,39]. However, our recent data
indicate that, although PARN is involved in the decay of a
reporter mRNA by tethered KSRP, it does not appear to play
a major role in the process while tethered KSRP primarily
relies on exosome function [6]. Thus, our present results are
in keeping with the idea that the exosome complex is the
main enzymatic machine recruited by KSRP to the RNA [6]. It
is noteworthy that a large-scale proteomic analysis identiﬁed
three exosome components (hRrp4p, hRrp41p, and hRrp45)
and the exosome-associated helicase hMtr4p, as well as KSRP
itself, as molecular partners of 14-3-3 [49].
The four KH domains that constitute the central core of
the KSRP are all necessary to ensure its interaction with the
entire decay-promoting machinery [6]. S193 lies in the ﬁrst
KH domain of KSRP. Therefore, it is not surprising that the
structural changes likely produced by phosphorylation, and
the consequent interaction with 14-3-3, severely impair the b-
catenin mRNA decay-promoting function of KSRP.
In conclusion, the expression levels of b-catenin have to be
tightly regulated. As the amount of b-catenin rises, it
accumulates in the nucleus, where it interacts with speciﬁc
transcription factors, leading to regulation of target genes.
Inappropriate activation of the b-catenin pathway is linked to
a wide range of cancers, including colorectal cancer and
melanoma. On the other hand, AKT has emerged as a crucial
regulator of widely divergent cellular processes including
apoptosis, differentiation, and metabolism. Disruption of
normal AKT signaling has now been documented as a
frequent occurrence in several human cancers, and it appears
to play an important role in their progression. The results we
obtained point to KSRP phosphorylation as a link between
PI3K-AKT signaling and the control of b-catenin mRNA t½
and, consequently, of its expression. PI3K-AKT signaling
activation, with consequent KSRP phosphorylation and
functional deactivation, might contribute to sustain b-catenin
accumulation and, as a result, activation of target genes
potentially able to accelerate tumor development.
Materials and Methods
Reagents. LY and insulin were obtained from Sigma (http://
www.sigmaaldrich.com); triciribine, from Calbiochem/EMD Bioscien-
ces (http://www.emdbiosciences.com); Wnt-3A, from R&D Systems
(http://www.rndsystems.com); and histone 2B, from Roche (http://www.
roche.com).
Plasmids. cDNA fragments containing mouse b-catenin cDNA
fragments (as shown in Figure S1) and GAPDH 39 UTR (nucleotides
580–810) were subcloned into PstI-XbaI–restricted pCY2 [39]. A
cDNA fragment containing the coding region of human KSRP
(nucleotides 202-2136) was cloned into the EcoRI-XhoI sites of
pCMV-Tag2B vector (Stratagene, http://www.stratagene.com) in frame
with the FLAG sequence to obtain a FLAG-KSRP plasmid. Muta-
genesis was performed using FLAG-KSRP and the QuickChange Site-
Directed Mutagenesis kit (Stratagene) to obtain FLAG-KSRP(S193A).
HA-myrAKT1 cassette was excised from the plasmid previously
described by Andjelkovic et al. [31] and subcloned into pcDNA3
(Invitrogen, http://www.invitrogen.com) to obtain pCMV-myr-AKT1,
AKT1(K179M) [50] in pUSEamp plasmid, and TOP-FLASH expres-
sion vectors were from Upstate Biotechnology (http://www.upstate.
com). Murine c-myc promoter ( 1,100 6 580) fused with Luciferase
was previously described [51]. To generate pCAT–b-catenin 39 UTR,
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restricted pcDNA3-CAT plasmid [4].
Recombinant proteins and antibodies. Afﬁnity-puriﬁed human
KSRP, expressed using the Baculovirus system, was described in
Briata et al. [9]. GST-KSRP deletion mutants were previously
described [4]. Amino acid 193 was mutagenized using the Quick-
Change Site-Directed Mutagenesis kit (Stratagene) to obtain GST–
KH1-2(S193A) and GST–KH1-4(S193A), respectively. GST–14-3-3
plasmid was constructed cloning the entire coding sequence of
mouse 14-3-3f into a pGEX vector.
Mouse monoclonal anti–14-3-3b (K-19, which recognizes all the 14-
3-3 family members), anti–14-3-3zeta (C-16, f–speciﬁc), anti-HuR
monoclonal antibody 3A2, and anti-HDAC2 were obtained from
Santa Cruz Biotechnology (http://www.scbt.com); mouse anti-GST was
from Chemicon (http://www.chemicon.com); rabbit anti-AKT was
from Cell Signaling (http://www.cellsignal.com); mouse anti–b-catenin
was from BD Transduction Laboratories (http://www.bdbiosciences.
com); anti-KSRP antibody [4] was afﬁnity puriﬁed and interacted with
both human and rodent KSRP [4,14, and R. Gherzi, unpublished
data]; and anti-hMtr4p [38] was generated against a hMtr4p(1–369)–
GST fusion protein and afﬁnity puriﬁed. Anti-AUF1 and anti-
hnRNP-A1 were a gift from Dr. Gideon Dreyfuss (Howard Hughes
Medical Institute), and anti-PARN, anti-hRrp41, anti-hRrp4p, and
anti-TTP polyclonal antibodies were gifts from Drs. Elmar Wahle
(University of Halle), Ger Pruijn (Nijmegen Center for Molecular Life
Sciences), David Tollervey (Wellcome Trust Centre for Cell Biology),
and William Rigby (Dartmouth Medical School), respectively. Anti-
FLAG (M2), anti–a-tubulin, and anti–b-actin monoclonal antibodies
were from Sigma.
Cells and transfections. Murine aT3-1 pituitary cells, rat HIRc-B
ﬁbroblasts, human HEK-293T cells (293T), and human HeLa cells
were cultured in DMEM plus 10% FBS, and murine C2C12 myoblasts
were cultured in DMEM plus 20% FBS. Cell transfections were
performed using LipofectAMINE Plus (Invitrogen), and G418
(Invitrogen) was used at 500 to 800 lg/ml (depending on the cell
line) for selection. Cell pools of transfectants were used for experi-
ments. aT3-1 cells were starved in DMEM plus 0.5% FBS for 16 h
prior to LiCl treatment, and aT3-1–myrAKT1 cells were starved in
DMEM plus 0.5% FBS for 16 h prior to experiments. HIRc-B cells
were starved in DMEM plus 0.1% FBS for 16 h prior to experiments
or further treatments. Transient transfections of aT3-1 with either
pcDNA3-CAT or pcDNA3-CAT–b-catenin plasmids were performed
as described in [4] with the exception that LipofectAMINE Plus was
used.
Semiquantitative and quantitative RT-PCR. Cells under different
culture conditions were treated with 5 lg/ml actinomycin D and
harvested at the indicated times, and total RNA was isolated using
RNeasy Mini Kit (Qiagen, http://www.qiagen.com) and treated with
DNase I (Promega, http://www.promega.com) according to the
manufacturer’s instructions. First-strand cDNA was obtained with
Transcriptor Reverse Transcriptase (Roche).
For semiquantitative RT-PCR, 250 ng of total RNA was retro-
transcribed using oligo-dT primer. b2-MG was used as an internal
control for normalizing transcripts levels measured by RT-PCR. To
optimize RT-PCR, preliminary dose-response experiments were
performed to determine the range of ﬁrst-strand cDNA concen-
trations at which PCR ampliﬁcation was linear for each target
molecule essentially as reported in Briata et al. [9]. For each species of
RNA analyzed, the amount of RT-PCR product (measured as
densitometric units) was plotted against the input of ﬁrst-strand
cDNA.
For quantitative RT-PCR, 150 ng of DNase I–treated total RNA was
retrotranscribed using random examers and PCRs were performed
using the IQ Sybr Green Mix Super (Bio-Rad, http://www.bio-rad.com)
and the MiniOpticon Real-Time PCR Detection System (Bio-Rad).
The sequence-speciﬁc primers used for PCRs are listed in Table S1.
RNA in vitro degradation and UV-crosslinking.
32P-labeled RNAs
were synthesized and used as substrates for in vitro degradation
assays as reported [7]. UV-crosslinking experiments were performed
as described [7].
Immunoprecipitation of ribonucleoprotein complexes. Ribonu-
cleoprotein complexes were immunoprecipitated from aT3-1 cell
lysates as previously described [7]. Total RNA, extracted from either
immunocomplexes or total cell lysates (input), was subjected to RT-
PCRs. Primers are listed in Table S1.
In vitro kinase assays and
32P orthophosphate metabolic labeling.
AKT (1 and 2) kinase assays were performed using preactivated
enzymes purchased from Upstate Biotechnology (50 ng of the active
enzyme/reaction) as recommended by manufacturer. [c-
32P]ATP
(3,000 Ci/mmol) was from Amersham Biosciences (http://www.
amersham.com). In vivo
32P orthophosphate metabolic labeling of
transiently transfected HeLa cells was performed as previously
described [52], incubating cells with orthophosphate for 16 h.
Isolation of phosphopeptides and LC-MS/MS and MS
3 analysis.
Puriﬁed recombinant KSRP was phosphorylated by AKT2 in standard
kinase assays. The reactions were analyzed by gel electrophoresis;
bands were excised, digested with trypsin, and enriched for
phosphopeptides using titanium dioxide microcolumns; and the
peptides were analyzed by automated nanoﬂow LC-MS/MS with a
method where the neutral loss of the phosphate group activate
the acquisition of a second fragment ion spectrum (an MS
3 spectrum)
as previously described in detail [53]. All MS/MS spectra ﬁles from
each LC run were centroided and merged to a single ﬁle, which was
searched using the MASCOT search engine (Matrix Science,
http://www.matrixscience.com) against the publicly available human
database.
shRNA-mediated KSRP knock-down. pSUPER-Puro-shKSRP was
previously described [9]. aT3-1 cells were transfected using Lipofect-
AMINE Plus (Invitrogen). Transfectant pools were selected with 0.3
lg/ml puromycin (Sigma).
Luciferase assays. Transient transfections of either mock aT3-1 or
aT3-1–shKSRP were carried out with LipofectAMINE Plus (Invitro-
gen). Luciferase activity was determined after 48 h with the Dual
Luciferase System (Promega) following the indications of the
manufacturer and using pRL-SV40 as a normalizing vector.
Supporting Information
Figure S1. b-Catenin mRNA Is Stabilized by myrAKT1 Expression in
Myoblasts C2C12
(A) In vitro RNA degradation assays using S100s from either mock
C2C12 or C2C12 cells expressing myrAKT1. Internally
32P-labeled
and capped RNA substrates were incubated with S100s for the
indicated times, and their decay was analyzed as described in
Materials and Methods.
(B) Semiquantitative RT-PCR analysis of b-catenin mRNA in either
mock C2C12 cells or C2C12 cells expressing myrAKT1. Total RNA
was isolated as indicated after the addition of actinomycin D. The
amount of each transcript was quantitated by densitometry and
plotted using a linear regression program. The values shown are
averages (6SEM) of three independent experiments performed in
duplicate.
Found at doi:10.1371/journal.pbio.0050005.sg001 (442 KB TIF).
Figure S2. KSRP Controls b-Catenin mRNA Decay In Vitro
(A) In vitro RNA degradation assays using S100s from either mock-
transfected (empty pSUPER-Puro vector) aT3-1 (mock aT3-1) or
pSUPER-Puro-shKSRP–transfected aT3-1 cells (aT3-1–shKSRP).
(B) In vitro RNA degradation assays using S100s from either LiCl-
treated mock-transfected aT3-1 cells or LiCl-treated FLAG-KSR–
transfected aT3-1 cells. Internally
32P-labeled and capped RNA
substrates were incubated with S100s for the indicated times, and
their decay was analyzed as described in Materials and Methods.
Found at doi:10.1371/journal.pbio.0050005.sg002 (792 KB TIF).
Figure S3. Neither KSRP Steady-State Levels nor Protein Stability Is
Affected by AKT1 Activation
(A) Immunoblot analysis of total extracts from the indicated cell lines
with anti-KSRP and a-tubulin antibodies.
(B) Either mock aT3-1 or aT3-1–myrAKT1 cells were treated with
cycloheximide (50 lg/ml) for the indicated times. Total cell extracts
were prepared and the levels of KSRP were quantitated by
immunoblotting and densitometric scanning. Results are the average
(6SEM) of three experiments. a-Tubulin immunoblotting was used to
verify the equal protein loading.
Found at doi:10.1371/journal.pbio.0050005.sg003 (341 KB TIF).
Figure S4. A Single mRNA Form Contains the Entire 39 UTR of
Mouse b-Catenin
RT-PCR analysis of total RNA from either mock aT3-1 cells
(untreated or treated as indicated) or aT3-1–myrAKT1. The primers
used are listed in Table S1 and schematically represented on the left.
Found at doi:10.1371/journal.pbio.0050005.sg004 (467 KB TIF).
Table S1. Primers Used for RT-PCRs
The primers used for RT-PCRs were m-b-catenin (mouse b-catenin),
m-AKT1 (mouse AKT1), r-b-catenin (rat b-catenin), b-C (the entire 39
PLoS Biology | www.plosbiology.org January 2007 | Volume 5 | Issue 1 | e5 0093
KSRP Required for b-Catenin mRNA DecayUTR of mouse b-catenin), m-b2-MG (mouse b2-MG), r-b2-MG (rat b2-
MG), CAT; CAT-b-catenin (the entire 39 UTR of mouse b-catenin
placed at the 39 of CAT), m-b-cat Q-PCR (mouse b-catenin for
quantitative PCRs, and m-b2-MG q-PCR (mouse b2-MG for quanti-
tative PCRs).
Found at doi:10.1371/journal.pbio.0050005.st001 (35 KB DOC).
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